Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cation channel sperm-associated auxiliary subunit theta (CATSPERQ), encoded by the TMEM249 gene, is an essential auxiliary component of the CatSper calcium channel complex embedded in sperm flagella. It serves as a structural scaffold required for the proper assembly, dimerization, and higher-order organization of the CatSper channel by stabilizing the pore-forming subunit CATSPER4 and potentially facilitating CatSper dimer formation. CATSPERQ specifically localizes to sperm flagella and is testis-specific. Its absence causes a complete loss of the CatSper channel from sperm, leading to defective sperm hyperactivation and male infertility. CATSPERQ is not currently known as a direct therapeutic target or biomarker, but mutations or deletions cause impaired sperm function and infertility in males[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cation channel sperm-associated auxiliary subunit theta (CATSPERQ).